ArticlePLoS neglected tropical diseases2025
Effective strategies for typhoid conjugate vaccine delivery: Health and economic insights from the 2015 Kampala outbreak.
Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Typhoid fever remains a major public health threat in low- and middle-income countries (LMICs), where inadequate access to clean water and sanitation drives recurrent outbreaks. With antimicrobial resistance on the rise, the urgency of deploying preventive strategies such as typhoid conjugate vaccines (TCVs) have grown. In this study, we developed a dynamic compartmental model calibrated to the 2015 typhoid outbreak in Kampala, Uganda, to assess the health and economic outcomes of various outbreak response immunization (ORI) strategies using TCVs. We aimed to identify optimal ORI strategies that minimize cases and typhoid-related deaths as well as the costs of implementation. Our model incorporated different phases of the outbreak, vaccine coverage levels (30%, 50%, 70%), timing (early, late, combined), and campaign duration. Cost-effectiveness was evaluated based on disability-adjusted life years (DALYs) and incremental cost-effectiveness ratios (ICERs), using World Health Organization (WHO) thresholds derived from Uganda's 2015 gross national income per capita. Early, high-coverage vaccination (Scenario 1) was most impactful reducing the effective reproduction number (Rt) below 1 during the epidemic peak and averting over 7,000 cases including 180 deaths. The timing of vaccine deployment was the most critical determinant of effectiveness, followed by coverage level and campaign duration. Our findings highlight the importance of rapid, high-coverage TCV deployment at the early stages of an outbreak. Strengthening disease surveillance and improving vaccine logistics are essential for a timely response. This modeling framework offers actionable evidence to support policy development and optimize outbreak preparedness in typhoid-endemic regions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.